EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS ABNORMAL

EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS ABNORMAL was reported 133 times

These drug classes are most commonly taken by patients reporting EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS ABNORMAL:

# Drug Count
0 Aromatase Inhibitor [EPC] 26
1 Corticosteroid [EPC] 22
2 Kinase Inhibitor [EPC] 21
3 Estrogen Receptor Antagonist [EPC] 18
4 Expectorant [EPC] 18
5 Nonsteroidal Anti-inflammatory Drug [EPC] 18
6 CD20-directed Cytolytic Antibody [EPC] 16
7 Calcineurin Inhibitor Immunosuppressant [EPC] 16
8 Calcium [EPC] 15
9 Programmed Death Receptor-1 Blocking Antibody [EPC] 13
10 Platinum-based Drug [EPC] 11
11 Calcium Channel Blocker [EPC] 7
12 Dihydropyridine Calcium Channel Blocker [EPC] 7
13 Microtubule Inhibitor [EPC] 7
14 RANK Ligand Inhibitor [EPC] 6
15 Janus Kinase Inhibitor [EPC] 4
16 Provitamin D2 Compound [EPC] 4
17 Vitamin B12 [EPC] 4
18 Factor Xa Inhibitor [EPC] 3
19 Folate Analog Metabolic Inhibitor [EPC] 3
20 Proteasome Inhibitor [EPC] 3
21 Serotonin-3 Receptor Antagonist [EPC] 3
22 Thalidomide Analog [EPC] 3
23 Benzodiazepine [EPC] 2
24 Nucleoside Metabolic Inhibitor [EPC] 2
25 Vascular Endothelial Growth Factor Inhibitor [EPC] 2
26 Angiotensin Converting Enzyme Inhibitor [EPC] 1
27 Azole Antifungal [EPC] 1
28 Bile Acid [EPC] 1
29 HER2/neu Receptor Antagonist [EPC] 1
30 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1
31 Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1
32 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1
33 Histamine-2 Receptor Antagonist [EPC] 1
34 Leukocyte Growth Factor [EPC] 1
35 Polyene Antifungal [EPC] 1
36 Topoisomerase Inhibitor [EPC] 1
37 Xanthine Oxidase Inhibitor [EPC] 1
38 alpha-Adrenergic Blocker [EPC] 1
39 mTOR Inhibitor Immunosuppressant [EPC] 1